Skip Navigation

 

Insight Sept./Oct. 2021

Insight Sept./Oct. 2021

Startup Aims to Stop Spread of Cancer with Engineered Antibodies

With assistance from Johns Hopkins Technology Ventures, the team secured nearly $2 million in funding and hopes to test its therapy in patients in the next five years.
back to top button